dizzy on tirzepatide Mounjaro (tirzepatide): Uses, Side Effects, Dosage & More Is Lightheadedness a Side Effect

Discovery of a potent and long-acting Xenopus GLP-1-based GLP-1/glucagon/Y2 receptor triple agonist

Importantly, only Semaglutide and Tirzepatide are FDA-approved and available todayRetatrutide remains investigational, with realistic approval falling between the second half of 2027 and mid-2028

Weight loss is one potential contributing factor

The FDA has received adverse event reports, some requiring hospitalization, involving dosing errors in which patients administered five to twenty times their intended dose due to unfamiliarity with vial-to-syringe measurement and confusion between units (milligrams vs

Routine BP checks at follow-up visits are usually sufficient